Skip to main content
Premium Trial:

Request an Annual Quote

Anne Schuchat to Retire

Anne Schuchat, the principal deputy director of the Centers for Disease Control and Prevention, is retiring after more than 30 years at the agency, according to Politico.

It notes that Schuchat has served as CDC's principal deputy director since 2015 and had key roles in its response to the H1N1 pandemic, SARS outbreak, and COVID-19 pandemic. The Washington Post adds that Schuchat was targeted by some Trump Administration officials who viewed her May 2020 analysis of the spread of COVID-19 as criticism of the administration. She additionally twice stepped in as acting CDC director, Politico adds.

According to Politico, Schuchat has recently been at odds with CDC Director Rochelle Walensky. However, Schuchat tells the Post that there is no friction in their relationship.

"Anne embodies selfless public service, the pinnacle of scientific and intellectual standards, and has given her heart to our agency and the public health community," Walensky says in a statement, according to the Post. "I will remain forever grateful that our paths crossed, even for just a short while."

Schuchat's announcement comes shortly after Nancy Messonnier, who led the CDC's vaccine task force, left the agency, Politico adds.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.